Veeva Shares Slide 4.7% as Salesforce Gains Drug Customers
Veeva Systems sees a 4.7% decline in share price as Salesforce attracts its pharmaceutical clients, challenging Veeva's market position.
Veeva is losing customers to Salesforce and saw a 4.7% drop in shares.